AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 12, 2005
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE TRANSITION PERIOD FROM ___________________ TO _____________
COMMISSION FILE NUMBER 0-14669
THE ARISTOTLE CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
|
DELAWARE |
06-1165854 |
|
(STATE OR OTHER JURISDICTION OF |
(I.R.S. EMPLOYER |
|
INCORPORATION OR ORGANIZATION) |
IDENTIFICATION NO.) |
96 CUMMINGS POINT ROAD, STAMFORD, CONNECTICUT
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
06902
(ZIP CODE)
(203) 358-8000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
As of May 12, 2005, 17,153,979 shares of Common Stock, 1,096,622 shares of Series I Preferred Stock and 10,984,971 shares of Series J Preferred Stock were outstanding.
THE ARISTOTLE CORPORATION
INDEX OF INFORMATION CONTAINED IN FORM 10-Q FOR THE
QUARTERLY PERIOD ENDED MARCH 31, 2005
|
PART I - FINANCIAL INFORMATION |
||||
|
Item 1. |
||||
|
Condensed Consolidated Balance Sheets at March 31, 2005 (unaudited), |
||||
|
1 |
||||
|
Condensed Consolidated Statements of Earnings for the Three Months |
||||
|
2 |
||||
|
Condensed Consolidated Statements of Cash Flows for the Three Months |
||||
|
3 |
||||
|
Notes to Condensed Consolidated Financial Statements (unaudited) |
4 |
|||
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and |
|||
|
10 |
||||
|
Item 3. |
15 |
|||
|
Item 4. |
16 |
|||
|
PART II - OTHER INFORMATION |
||||
|
Item 6. |
17 |
|||
PART I
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
|
Assets |
March 31, 2005 |
December 31, 2004 |
March 31, 2004 |
||||||
|
(unaudited) |
(unaudited) |
||||||||
|
Current assets: |
|||||||||
|
Cash and cash equivalents |
$ |
795 |
2,143 |
1,766 |
|||||
|
Investments |
4,131 |
4,058 |
- |
||||||
|
Accounts receivable, net |
16,866 |
12,592 |
15,082 |
||||||
|
Inventories |
36,848 |
33,356 |
31,718 |
||||||
|
Prepaid expenses and other |
6,032 |
6,665 |
5,564 |
||||||
|
Refundable income taxes |
- |
49 |
326 |
||||||
|
Deferred income taxes |
9,825 |
9,825 |
8,184 |
||||||
|
Total current assets |
74,497 |
68,688 |
62,640 |
||||||
|
Property, plant and equipment, net |
17,901 |
17,405 |
17,038 |
||||||
|
Goodwill |
13,685 |
13,707 |
11,466 |
||||||
|
Deferred income taxes |
9,047 |
10,594 |
13,612 |
||||||
|
Other assets |
463 |
511 |
427 |
||||||
|
Total assets |
$ |
115,593 |
110,905 |
105,183 |
|||||
|
Liabilities and Stockholders' Equity |
|||||||||
|
Current liabilities: |
|||||||||
|
Current installments of long-term debt |
$ |
115 |
114 |
3,584 |
|||||
|
Trade accounts payable |
7,789 |
7,192 |
6,720 |
||||||
|
Accrued expenses |
4,954 |
5,833 |
4,583 |
||||||
|
Accrued dividends payable |
- |
2,158 |
- |
||||||
|
Total current liabilities |
12,858 |
15,297 |
14,887 |
||||||
|
Long-term debt, less current installments |
30,910 |
24,948 |
29,369 |
||||||
|
Stockholders' equity: |
|||||||||
|
Preferred stock, Series I, convertible, voting, 11% cumulative, $6.00 |
|||||||||
|
stated value; $.01 par value; 2,400,000 shares authorized, |
|||||||||
|
1,096,622 shares issued and outstanding |
6,580 |
6,580 |
6,580 |
||||||
|
Preferred stock, Series J, non-voting, 12% cumulative, $6.00 stated value; |
|||||||||
|
$.01 par value; 11,200,000 shares authorized, 10,984,971 shares |
|||||||||
|
issued and outstanding |
65,760 |
65,760 |
65,760 |
||||||
|
Common stock, $.01 par value; 20,000,000 shares authorized, 17,148,979, |
|||||||||
|
17,142,779 and 17,111,354 shares issued and outstanding at |
|||||||||
|
March 31, 2005, December 31, 2004 and March 31, 2004, |
|||||||||
|
respectively |
171 |
171 |
171 |
||||||
|
Additional paid-in capital |
2,483 |
2,310 |
1,060 |
||||||
|
Accumulated deficit |
(3,301) |
(4,331) |
(12,375) |
||||||
|
Accumulated other comprehensive earnings (loss) |
132 |
170 |
(269) |
||||||
|
Total stockholders' equity |
71,825 |
70,660 |
60,927 |
||||||
|
Total liabilities and stockholders' equity |
$ |
115,593 |
110,905 |
105,183 |
|||||
The accompanying notes are an integral part of these condensed consolidated financial statements
.1
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(in thousands, except share and per share data)
(Unaudited)
|
Three Months Ended |
||||||
|
March 31, |
||||||
|
2005 |
2004 |
|||||
|
Net sales |
$ |
41,748 |
39,020 |
|||
|
Cost of sales |
25,685 |
23,831 |
||||
|
Gross profit |
16,063 |
15,189 |
||||
|
Selling and administrative expense |
10,633 |
9,876 |
||||
|
Earnings from operations |
5,430 |
5,313 |
||||
|
Other expense (income): |
||||||
|
Interest expense |
291 |
313 |
||||
|
Other, net |
(70) |
30 |
||||
|
221 |
343 |
|||||
|
Earnings before income taxes |
5,209 |
4,970 |
||||
|
Income taxes: |
||||||
|
Current |
465 |
456 |
||||
|
Deferred |
1,556 |
1,469 |
||||
|
2,021 |
1,925 |
|||||
|
Net earnings |
3,188 |
3,045 |
||||
|
Preferred dividends |
2,158 |
2,163 |
||||
|
Net earnings applicable to common stockholders |
$ |
1,030 |
882 |
|||
|
Earnings per common share: |
||||||
|
Basic |
$ |
.06 |
.05 |
|||
|
Diluted |
$ |
.06 |
.05 |
|||
|
Weighted average common shares outstanding: |
||||||
|
Basic |
17,144,992 |
17,099,002 |
||||
|
Diluted |
17,407,253 |
17,280,043 |
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
|
Three Months Ended |
||||||||||
|
March 31, |
||||||||||
|
2005 |
2004 |
|||||||||
|
Cash flows from operating activities: |
||||||||||
|
Net earnings |
$ |
3,188 |
3,045 |
|||||||
|
Adjustments to reconcile net earnings to net cash |
||||||||||
|
provided by (used in) operating activities: |
||||||||||
|
Depreciation and amortization |
429 |
416 |
||||||||
|
Stock option compensation |
149 |
125 |
||||||||
|
(Gain) loss on sale of property, plant and equipment |
1 |
(2) |
||||||||
|
Earnings in equity method investment |
(73) |
- |
||||||||
|
Deferred income taxes |
1,556 |
1,469 |
||||||||
|
Change in assets and liabilities: |
||||||||||
|
Accounts receivable |
(4,274) |
(3,201) |
||||||||
|
Inventories |
(3,492) |
(2,561) |
||||||||
|
Prepaid expenses and other |
633 |
34 |
||||||||
|
Other assets |
70 |
70 |
||||||||
|
Trade accounts payable |
597 |
846 |
||||||||
|
Accrued expenses and other liabilities |
(851) |
29 |
||||||||
|
Net cash provided by (used in) operating activities |
(2,067) |
270 |
||||||||
|
Cash flows from investing activities: |
||||||||||
|
Purchases of property, plant and equipment |
(946) |
(278) |
||||||||
|
Proceeds from the sale of property, plant and equipment |
- |
2 |
||||||||
|
Net cash used in investing activities |
(946) |
(276) |
||||||||
|
Cash flows from financing activities: |
||||||||||
|
Proceeds from issuance of long-term debt |
6,000 |
2,500 |
||||||||
|
Principal payments on long-term debt |
(37) |
(2,136) |
||||||||
|
Proceeds from issuance of stock under stock option plans |
18 |
159 |
||||||||
|
Preferred dividends paid |
(4,316) |
(4,317) |
||||||||
|
Net cash provided by (used in) financing activities |
1,665 |
(3,794) |
||||||||
|
Net decrease in cash and cash equivalents |
(1,348) |
(3,800) |
||||||||
|
Cash and cash equivalents at beginning of period |
2,143 |
5,566 |
||||||||
|
Cash and cash equivalents at end of period |
$ |
795 |
1,766 |
|||||||
|
Supplemental cash flow information |
||||||||||
|
Cash paid during the period for: |
||||||||||
|
Interest |
$ |
278 |
334 |
|||||||
|
Income taxes |
$ |
408 |
357 |
|||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
The Aristotle Corporation ("Aristotle") and its subsidiaries (together with Aristotle, the "Company"), founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products. A selection of over 80,000 items is offered, primarily through more than 45 separate catalogs carrying the brand of Nasco (founded in 1941), as well as those bearing the brands of Life/Form®, Whirl-Pak®, Simulaids, Triarco, Spectrum Educational Supplies, Hubbard Scientific, Scott Resources, Haan Crafts, To-Sew, CPR Prompt®, Ginsberg Scientific and Summit Learning. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials, medical simulators and items for the agricultural, senior care and food industries. In addition, the Company offers simulation kits and manikins used for training in cardiopulmonary resuscitation and the fire and emergency rescue and patient care fields. The Company also markets proprietary product lines that provide exclusive distribution rights throughout all of its catalogs. The proprietary product lines are developed internally through the Company's research and development efforts and acquired externally by licensing rights from third parties. The Company's inventories primarily consist of finished goods and catalog merchandise.
Geneve Corporation ("Geneve"), a privately-held diversified financial holding company, and its affiliated entities held greater than 90% of Aristotle's voting power at March 31, 2005 and 2004.
Financial Statement Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with
U.S. generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Condensed Consolidated Financial Statements do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of March 31, 2005 and 2004, and results of operations and cash flows for the three months ended March 31, 2005 and 2004, as applicable, have been made. Operating results for the three months ended March 31, 2005 are n ot necessarily indicative of results that may be expected for any other interim period or for the year ending December 31, 2005. For further information, refer to the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2004.
All significant intercompany balances and transactions have been eliminated in consolidation.
In March 2005, the Financial Accounting Standards Board
(the "FASB") issued Interpretation No. 47, Accounting for Conditional Asset Retirement Obligations ("FIN 47"). FIN 47 clarifies that an entity must record a liability for a "conditional" asset retirement obligation if the fair value of the obligation can be reasonably estimated. The provision is effective no later than the end of fiscal years ending after December 15, 2005. The Company is in the process of determining what effect, if any, FIN 47 will have on its financial position or results of operations for 2005.
4
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
In March 2005, the Securities and Exchange Commission (the "SEC") announced that it had extended the compliance dates for non-accelerated filers and foreign private issuers to include in their annual reports a report by management on a company's internal control over financial reporting and an accompanying auditor's report (the "SEC Release"). The internal control reports are required by Section 404 of the Sarbanes-Oxley Act of 2002. The Company is a non-accelerated filer as defined under relevant SEC regulations. As a result of the SEC Release, the Company will not be required to include internal control reports in its annual report until its 2006 annual report, which will be filed by the Company in 2007.
In December 2004, the FASB issued a revised Statement of Financial Accounting Standards ("SFAS") No. 123, Share-Based Payment ("SFAS 123R"), which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services and incurs liabilities in exchange for goods or services. SFAS 123R requires a company to measure the cost of employee services received in exchange for an award of equity instruments, such as stock options, based on the grant-date fair value of the award and to recognize these awards as an expense in the statement of earnings over the requisite service period. The grant-date fair value of employee stock options and similar instruments will be estimated using option-pricing models adjusted for unique characteristics of those instruments unless observable market prices for the same or similar instruments are available. SFAS 123R replaces SFAS No. 123, Accounting for Stock-Based Compensation, which wa s issued in October 1995. SFAS 123R is effective for all awards granted, modified, repurchased, or cancelled after the beginning of the first annual reporting period beginning after June 15, 2005. SFAS 123R provides for methods of applying this statement to existing awards during the transitional period. The adoption of SFAS 123R is not expected to have a material impact on the Company's financial statements.
In November 2004, the FASB issued SFAS No. 151, Inventory Costs: an amendment of ARB No. 43 ("SFAS 151"), which clarifies that abnormal costs of idle facility expense, freight, handling costs and wasted material should be recognized as current period expenses. SFAS 151 also requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. SFAS 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. The adoption of SFAS 151 is not expected to have a material impact on the Company's financial statements.
In December 2003, the FASB issued a revised Interpretation No. 46, Consolidation of Variable Interest Entities ("Interpretation 46R"), which addresses how a business enterprise should evaluate whether it has a controlling financial interest in an entity through means other than voting rights and accordingly should consolidate the entity. Interpretation 46R replaces Interpretation No. 46, Consolidation of Variable Interest Entities, which was issued in January 2003. The Company is required to apply Interpretation 46R to interests in variable interest entities ("VIE") created after December 31, 2003. For variable interests in a VIE created before January 1, 2004, the interpretation will be applied beginning on January 1, 2005. For any VIE that must be consolidated under Interpretation 46R that was created before January 1, 2004, the assets, liabilities and noncontrolling interests of the VIE initially would be measured at its carrying amounts with any difference between the net amount added to the balance sheet and any previously recognized interest being recognized as the cumulative effect of an accounting change. If determining the carrying amounts is not practicable, fair value at the date Interpretation 46R first applies may be used to measure the assets, liabilities and noncontrolling interest of the VIE. The adoption of Interpretation 46R did not have a material impact on the Company's financial statements for the three months ended March 31, 2005.
5
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
On September 17, 2004, Aristotle purchased certain assets of the science product line of Ginsberg Scientific Company and GSC International, Inc. (collectively referred to as "Ginsberg") for $1.8 million. Ginsberg is a manufacturer and distributor of products and kits designed to demonstrate certain science concepts for students in grades 5-12. The Ginsberg offerings complement the science product lines manufactured and distributed by the Company in the educational segment. The results of Ginsberg's operations have been included in the Company's consolidated financial statements since the date of such acquisition. The purchase price allocation resulted in goodwill of $1.0 million attributable to the educational segment.
On August 11, 2004, Aristotle purchased certain assets of the CPR Prompt product line from Cardiac Science, Inc. for $1.9 million. The CPR Prompt product line is comprised of a number of products, primarily training manikins, used in the instruction of cardiopulmonary resuscitation. The CPR Prompt product line complements product lines manufactured and distributed by the Company in the educational segment. The results of CPR Prompt's operations have been included in the Company's consolidated financial statements since the date of such acquisition. The purchase price allocation resulted in goodwill of $1.0 million attributable to the educational segment.
Basic earnings per common share is calculated by dividing net earnings applicable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings applicable to common stockholders by the weighted average number of common shares outstanding during the period and including each share that would have been outstanding assuming the issuance of common shares for all dilutive potential common shares outstanding during the period.
Shares of Common Stock available for issue upon conversion of the 1,096,622 shares of Series I Preferred Stock outstanding at March 31, 2005 and 2004, were not dilutive and, therefore, have not been included in the computations of diluted earnings per common share amounts for the periods then ended.
Prior to February 2005, the Company invested in a limited partnership, the general partner
of which is an affiliate of the Company. In February 2005, the then-balance of the investment, approximately $4.1 million, was transferred to another limited partnership, the general partner of which is an affiliate of the Company; the assets of the limited partnership are managed exclusively by a non-affiliate of the Company. The purpose of the limited partnership in which the Company is currently invested is to manage a diversified investment portfolio. The Company's investment is accounted for under the equity method of accounting, which equates the carrying value of the investment to the Company's equity in the partnership's underlying book value. The Company's equity earnings or loss is credited or charged, as appropriate, to other income within the Condensed Cons olidated Statements of Earnings. Equity earnings amounted to less than $.1 million for the three months ended March 31, 2005. No amounts were invested or earned for the three months ended March 31, 2004.
6
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
Changes in stockholders' equity for the three months ended March 31 are as follows (in thousands):
|
|
|
2005 |
2004 |
|||||||
|
Balance at January 1 |
$ |
70,660 |
59,844 |
|||||||
|
Net earnings |
3,188 |
3,045 |
||||||||
|
Exercise of stock options, including related |
||||||||||
|
tax benefit |
24 |
243 |
||||||||
|
Stock option compensation |
149 |
125 |
||||||||
|
Other comprehensive loss: |
||||||||||
|
Foreign currency translation adjustment |
(38) |
(167) |
||||||||
|
Preferred dividends |
(2,158) |
(2,163) |
||||||||
|
Balance at March 31 |
$ |
71,825 |
60,927 |
|||||||
Comprehensive earnings for the three months ended March 31 is as follows (in thousands):
|
|
|
2005 |
2004 |
||
|
Net earnings |
$ |
3,188 |
3,045 |
||
|
Foreign currency translation adjustment |
(38) |
(167) |
|||
|
Comprehensive earnings |
$ |
3,150 |
2,878 |
Stock Options
The Company accounts for its stock options under the fair value-based recognition and measurement provisions of SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS 123"), which requires the fair value of stock options granted to employees to be measured at the date of grant and recognized as an expense over the service period, which is usually the vesting period of the grant. Under SFAS 123, the Company recognizes the fair value of stock options as an expense within its Condensed Consolidated Statements of Earnings.
The Company has a 1997 Employee and Director Stock Plan ("1997 Plan") and 2002 Employee, Director and Consultant Stock Plan ("2002 Plan"). The Company does not currently intend to grant any additional options under the 1997 Plan. No stock options were granted under the 2002 Plan during each of the three months ended March 31, 2005 and 2004. The total estimated fair value of options granted under the 2002 Plan is generally recognized as non-cash compensation expense over the three year vesting period for such options. The Company recorded compensation expense related to granted stock options of approximately $.1 million for each of the three months ended March 31, 2005 and 2004. The expected annual impact of the options granted to date on 2005 earnings before income taxes is a reduction of approximately $.4 million.
Prior to September 10, 2004, the Company had two noncontributory defined benefit pension plans covering substantially all salaried and hourly employees. On September 10, 2004, the Company merged both of its defined benefit pension plans with a defined benefit pension plan of an affiliate. As a result of the plan merger, the Company has a single defined benefit pension plan covering substantially all salaried and hourly employees of the Company.
7
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
No contributions were made to the pension plan for each of the three months ended March 31, 2005 and 2004. The Company expects to contribute a total of $1.3 million to the pension plan in 2005.
The following table presents the components of net periodic benefit cost for the three months ended March 31 (in thousands):
|
2005 |
2004 |
||||||
|
Service cost |
$ |
172 |
157 |
||||
|
Interest cost |
209 |
203 |
|||||
|
Expected return on plan assets |
(238) |
(212) |
|||||
|
Amortization of transition asset |
- |
(7) |
|||||
|
Amortization of prior service cost |
(1) |
(1) |
|||||
|
Recognized net actuarial loss |
71 |
54 |
|||||
|
Net periodic benefit cost |
$ |
213 |
194 |
||||
Segment Reporting
The Company's business activities are organized into two business segments, educational and commercial. The educational segment relates to instructional teaching aids and materials, which are distributed to educational institutions principally in North America, for kindergarten through grade 12 classes, and for nursing school and emergency medical instructors. Products in the educational segment are marketed primarily through catalogs. The growth potential of the educational segment is directly related to school enrollments and the strength of government funding of education. The commercial segment relates to agricultural products, sterile sampling containers and systems, materials for nursing home activities and novelty and gift products. Products in the commercial segment are marketed through catalogs nationwide and through a worldwide dealer network covering more than 60 countries. Market growth in the commercial segment is principally impacted by the general e conomic conditions of world agriculture, the increasing size of the aged population, as well as increasing global awareness of food and water quality standards. The Company evaluates the performance of these segments based on segment net sales and gross profit.
The following table presents segment information for the three months ended March 31 (in thousands):
|
|
|
2005 |
2004 |
||||
|
Net sales: |
|
|
|
||||
|
|
Educational |
$ |
33,944 |
31,078 |
|||
|
|
Commercial |
|
7,804 |
7,942 |
|||
|
|
|
Net sales |
$ |
41,748 |
39,020 |
||
|
Gross profit: |
|
||||||
|
|
Educational |
$ |
14,097 |
13,184 |
|||
|
|
Commercial |
|
2,906 |
2,858 |
|||
|
|
Other costs of sales |
|
(940) |
(853) |
|||
|
|
|
Gross profit |
$ |
16,063 |
15,189 |
||
8
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2005
(Unaudited)
Other costs of sales primarily include freight costs incurred in the procurement of inventories and shipment of customer orders not allocable to a particular segment.
The following table presents segment identifiable asset information as of March 31, 2005, December 31, 2004 and March 31, 2004 (in thousands):
|
March 31, |
|
December 31, |
March 31, |
|||||
|
2005 |
2004 |
2004 |
||||||
|
Identifiable assets: |
|
|
|
|||||
|
|
Educational |
$ |
59,669 |
53,900 |
49,457 |
|||
|
|
Commercial |
|
5,705 |
4,832 |
5,325 |
|||
|
|
Other corporate assets |
|
50,219 |
52,173 |
50,401 |
|||
|
|
|
Identifiable assets |
$ |
115,593 |
110,905 |
105,183 |
||
Educational assets include $13.7 million, $13.7 million and $11.5 million of goodwill at March 31, 2005, December 31, 2004 and March 31, 2004, respectively.
9
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
GENERAL
This discussion and analysis of financial condition and results of operations reviews the results of operations of the Company, on a consolidated basis, for the three months ended March 31, 2005 as compared to the three months ended March 31, 2004. This discussion and analysis of financial condition and results of operations has been derived from, and should be read in conjunction with, the unaudited Condensed Consolidated Financial Statements and Notes to Condensed Consolidated Financial Statements contained herein.
The Company is a leading manufacturer and